http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : ( Kam Lun Hon ) (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
( Kam Lun Hon ) 한국피부장벽학회 2013 한국피부장벽학회지 Vol.15 No.2
Atopic dermatitis (AD) is a chronically relapsing dermatitis associated with pruritus, sleep disturbance, psychosocial symptoms and impaired quality of life. Avoidance of triggering factors, optimal skin care, topical corticosteroids and calcineurin inhibitors are the mainstay of therapy for AD. Recent advances in the understanding of the pathophysiological process of AD involving filaggrin and ceramide metabolism has led to the concept of barrier therapy and production of new moisturizers and topical skin products targeted to correct reduced amounts of ceramides and natural moisturizing factors in the skin. Although some of these commercial products show promising effects, efficacy on skin biophysiologic, clinical and psychosocial parameters have not been consistently demonstrated. Well-designed, large scale, randomized, placebo-controlled trials to document therapeutic effects on disease severity, dermatologic biophysical parameters, quality of life and patient acceptability are needed. The ideal skin barrier therapeutic agent is yet to be invented.
-
( Kam Lun Hon ) 한국피부장벽학회 2013 한국피부장벽학회지 Vol.15 No.2
Atopic dermatitis (AD) is a chronically relapsing dermatitis associated with pruritus, sleep disturbance, psychosocial symptoms and impaired quality of life. Avoidance of triggering factors, optimal skin care, topical corticosteroids and calcineurin inhibitors are the mainstay of therapy for AD. Recent advances in the understanding of the pathophysiological process of AD involving filaggrin and ceramide metabolism has led to the concept of barrier therapy and production of new moisturizers and topical skin products targeted to correct reduced amounts of ceramides and natural moisturizing factors in the skin. Although some of these commercial products show promising effects, efficacy on skin biophysiologic, clinical and psychosocial parameters have not been consistently demonstrated. Well-designed, large scale, randomized, placebo-controlled trials to document therapeutic effects on disease severity, dermatologic biophysical parameters, quality of life and patient acceptability are needed. The ideal skin barrier therapeutic agent is yet to be invented.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
